Catalyst Pharmaceuticals Inc (CPRX)
EBITDA Growth
16.42%
Quarterly · Period ending:
CPRX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported16.42%period ending
Latest reported16.42%period ending
CPRX Quarterly EBITDA YoY % (-389.67% → 16.42%)
Year-over-year change
High-resolution chart · PNG
CPRX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 16.4169% | |
| -2.6315% | |
| 20.6958% | |
| 20.7442% | |
| 109.6264% | |
| 49.7565% | |
| 328.3678% | |
| 14.2619% | |
| -12.2834% | |
| 66.1065% | |
| -209.8946% | |
| 101.8316% | |
| 151.0318% | |
| 161.7391% | |
| 88.3287% | |
| 77.5281% | |
| 76.7327% | |
| 48.5203% | |
| 20.1892% | |
| 45.2235% | |
| -8.1563% | |
| 4.4895% | |
| -17.6278% | |
| -3.9073% | |
| 1,206.4443% | |
| 155.8143% | |
| 274.2881% | |
| 280.4144% | |
| 83.562% | |
| -169.4128% | |
| -90.3484% | |
| -51.8043% | |
| -26.9667% | |
| -26.6752% | |
| -9.9714% | |
| 13.263% | |
| 25.0215% | |
| 29.7458% | |
| 22.0056% | |
| 1.6911% | |
| -45.3006% | |
| -55.5776% | |
| -22.0483% | |
| -63.8139% | |
| -22.2857% | |
| -47.1888% | |
| -26.5959% | |
| -12.6998% | |
| -106.0555% | |
| -79.7576% | |
| -152.9352% | |
| -148.7027% | |
| -24.8296% | |
| 25.8476% | |
| -14.0117% | |
| 22.6512% | |
| 9.975% | |
| -179.2304% | |
| -24.5311% | |
| -3.7406% | |
| -44.9524% | |
| 37.578% | |
| 29.7879% | |
| 24.6568% | |
| 65.6295% | |
| 69.2691% | |
| 55.7903% | |
| 28.2813% | |
| -76.9704% | |
| -233.3623% | |
| -206.925% | |
| -71.1817% | |
| -14.7666% | |
| -28.3212% | |
| 29.3316% | |
| -301.8389% | |
| -348.4096% | |
| 33.0837% | |
| -454.0863% | |
| 45.9834% | |
| 49.5468% | |
| -879.3427% | |
| -79.2108% | |
| -389.6714% | |
| -389.6714% |